CYP24A1 and hypercalcemia disease: Among cases of vitamin D-sensitive hypercalcemia in children, a 25(OH)D3:24,25(OH)2D3 ratio > 25 with upregulated alternative metabolism via 3-epi-25(OH)D3 has been described to clinically identify CYP24A1’s loss of function [68].